Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Infection in 2019 (COVID-19)”

Showing 20 of 0 results

Not applicableStudy completedNCT04061382
What this trial is testing

Sero-epidemiological Survey of England in 2019/2020 - COVID-19

Who this might be right for
Serogroup C Meningococcal MeningitisDiphtheriaCOVID-19
University of Oxford 2,963
Large-scale testing (Phase 3)UnknownNCT04353180
What this trial is testing

Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)

Who this might be right for
COVID19
Kafrelsheikh University 100,000
Not applicableStudy completedNCT05410808
What this trial is testing

Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 Pandemic

Who this might be right for
FibromyalgiaCoronavirus Disease 2019 Pandemic
Ege University 78
Early research (Phase 1)WithdrawnNCT04464460
What this trial is testing

Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

Who this might be right for
Coronavirus Disease
Takeda
Early research (Phase 1)Study completedNCT05656508
What this trial is testing

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Who this might be right for
COVID-19 Vaccine
Laboratorio Pablo Cassara S.R.L. 80
Testing effectiveness (Phase 2)Study completedNCT07134725
What this trial is testing

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Who this might be right for
COVID - 19
Federal University of Minas Gerais 432
Testing effectiveness (Phase 2)Ended earlyNCT05375760
What this trial is testing

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
AstraZeneca 251
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Early research (Phase 1)Study completedNCT04646044
What this trial is testing

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30
Large-scale testing (Phase 3)UnknownNCT05091411
What this trial is testing

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 1,680
Testing effectiveness (Phase 2)Study completedNCT04478071
What this trial is testing

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirus Infection
The University of Texas Health Science Center, Houston 448
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Not applicableUnknownNCT04346056
What this trial is testing

Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19

Who this might be right for
Coronavirus Disease (COVID-19)COVID-19
Ain Shams University 500
Not applicableUnknownNCT06142201
What this trial is testing

A Real-World Study of JT001 for COVID-19

Who this might be right for
COVID-19
Shanghai Vinnerna Biosciences Co., Ltd. 7,656
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Early research (Phase 1)Study completedNCT04644120
What this trial is testing

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
CoronaVirus Disease-2019 (COVID-19)
AbbVie 25
Not applicableUnknownNCT04659135
What this trial is testing

ASCO Survey on COVID-19 in Oncology (ASCO) Registry

Who this might be right for
NeoplasmsCoronavirus
American Society of Clinical Oncology 7,000
Not applicableStudy completedNCT04389944
What this trial is testing

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Who this might be right for
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
University Hospital, Basel, Switzerland 15
Large-scale testing (Phase 3)UnknownNCT05187793
What this trial is testing

Study of Efficacy of Different Treatment Regimens of Olokizumab

Who this might be right for
COVID-19
R-Pharm 198
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation